XML 78 R65.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information -Reconciliation of Total Adjusted EBITDA to Consolidated Income (Loss) Before Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Adjusted EBITDA $ 688,657 $ 670,795 $ 593,770
Interest expense, net (126,668) (130,299) (109,414)
Depreciation and amortization, including patient equipment depreciation (365,334) (382,783) (351,178)
Share-Based Payment Arrangement, Expense (14,880) (22,468) (22,397)
Change in fair value of warrant liability 4,021 34,482 17,158
Goodwill impairment (13,078) (830,787) 0
Loss on extinguishment of debt (2,273) 0 0
Other loss, net (2,793) (29,566) (253)
Income (loss) before income taxes 136,019 (723,784) 97,902
Systems implementation activities 13,900 5,600 11,700
Asset dispositions 4,500    
Legal Fees 4,200 13,900 10,500
Severance charges 3,900 7,100  
Asset impairment charges 2,700   800
Other nonoperating expense 1,900 1,600 3,900
Cost saving initiatives 5,200    
Lease termination cost   4,800  
Operating lease, impairment loss   900  
TRA   (2,500) (2,900)
Chief Executive Officer      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Severance charges   2,900  
Pending Litigation      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Litigation settlement expense (2,400)    
Pending Litigation | Derivative Plaintiff      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Litigation settlement expense (900)    
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]      
Interest expense, net (126,668) (130,299) (109,414)
Depreciation and amortization, including patient equipment depreciation (365,334) (382,783) (351,178)
Share-Based Payment Arrangement, Expense (14,880) (22,468) (22,397)
Change in fair value of warrant liability 4,021 34,482 17,158
Goodwill impairment (13,078) (830,787) 0
Loss on extinguishment of debt (2,273) 0 0
Litigation settlement expense (3,338) (25,140) 0
Other loss, net $ (31,088) $ (37,584) $ (30,037)